310164 items (310164 unread) in 46 feeds
World Health Organization
(748 unread)
Media
(241843 unread)
Bird Flu
(5365 unread)
Diabetes
(11091 unread)
Cholesterol
(4298 unread)
Cancer
(23007 unread)
HIV
(12622 unread)
Women
(8661 unread)
Men
(2529 unread)
Cancer (100 unread)
Published: Tuesday, March 9, 2010 at 5:12 a.m. Last Modified: Tuesday, March 9, 2010 at 5:12 a.m. Researchers at Johns Hopkins University have developed a way to monitor the progress of a patient's cancer treatment using a new technique for rapidly sequencing, or decoding, large amounts of DNA.
Main Category: Biology / Biochemistry Also Included In: Cancer / Oncology Article Date: 10 Mar 2010 For the first time, scientists have succeeded in growing empty particles derived from a plant virus and have made them carry useful chemicals.
Colon cancer survivors who are moderately or severely obese face tougher survival odds following treatment compared with their normal-weight peers, a new study reveals.
Dendreon Corporation today announced updated results from its pivotal Phase 3 IMPACT study demonstrating that PROVENGE extends overall survival in men with metastatic, castrate-resistant prostate cancer .
At left, Stephen Duckett, president and CEO of Alberta Health Services. At right, Alberta Premier Ed Stelmach.
New breakthrough treatments for the most common cancers could soon come from cutting-edge research into some of the world's rarest tumors.
TWO patients had a delayed cancer diagnosis when almost 58,000 X-rays taken at Tallaght Hospital in Dublin were not reviewed by a consultant radiologist.
A street vendor prepares papaya for her daily customers in Yangon. Researchers say that papaya leaf extract and its tea have dramatic cancer-fighting properties against a broad range of tumours, backing a belief held in a number of folk traditions.
Researchers in Alberta have successfully tested a new viral approach to treating prostate cancer in a small number of men.
Another weapon in the arsenal against cancer: Nanoparticles that identify, target and kill specific cancer cells while leaving healthy cells alone.
Postmenopausal women, including those over 70 years old, who have been newly diagnosed with cancer in one breast have higher cancer detection rates when the other breast is scanned for tumors with MRI, compared to premenopausal women, say researchers at the Mayo Clinic campus in Florida.

New Delhi, March 9 After successfully treating hundreds of cancer patients in India, a Noida-based institute has now accepted an offer from Malaysia to provide targeted 'dendritic cell' therapy to patients there.
A federal judge refused to dismiss 40 lawsuits against a Swedish-based pharmaceutical company accused of failing to warn patients that two of its drugs can cause severe jaw deterioration.
Spaying is a procedure few of us question. This year alone, thousands of female dogs will undergo the hysterectomy operation, which removes the ovaries and uterus.
US biotechnology company Biogen Idec and Swiss drugmaker Roche Holding are suspending rheumatoid arthritis and lupus treatment ocrelizumab after it caused deaths, casting doubt over the drug's future.
US Oncology, Inc., the leading oncology services company uniting the nation's largest cancer treatment and research network to expand patient access to high-quality, cost-effective cancer care and advance the science of cancer care, has been named to FORTUNE magazine's World's Most Admired Companies list for 2010.
It's the Journey , Atlanta's premier breast cancer non-profit organization and producer of the Atlanta 2-Day Walk for Breast Cancer, granted $770,000 to 20 Atlanta-area breast cancer organizations at its 7th Annual Grant Party on March 1. The money, raised through the 2009 Atlanta 2-Day Walk for Breast Cancer , by walkers, sponsors, and donors, ...
The American Cancer Society Relay For Life of Frankfort/Mokena will join with other communities across the nation this summer to "Celebrate. Remember.
Treating cancer with just one injection? It may sound unbelievable, but an Indian medical institute is soon to start human trials to treat cancer in six weeks through a solitary injection dose.
To read this article in full you must have registered and have a Premium Content Subscription with the NHS Choices site.
A new report published in the American Cancer Society journal, CA: A Cancer Journal for Clinicians , and in the American Heart Association journal, Circulation , reveals that androgen-deprivation therapy , a type of prostate cancer treatment, can increase heart risk factors and possibly lead to heart attack or cardiac death.
Transgene Biotek has filed two patents for its cancer drug technologies - one for liver cancer and the other for breast cancer - both based on its proprietary RNAi platform.
Members of America's Prostate Cancer Organizations are concerned that the issuance this morning of yet another set of new guidelines on screening for prostate cancer is only adding to the confusion most men already feel about whether they should or shouldn't be tested for the most common form of cancer in American men.
Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium SOUTH SAN FRANCISCO, Calif.
Responding to continued debate over PSA screening, and today's American Cancer Society statement, the Prostate Cancer Foundation reiterated its position that PSA screening remains a valuable tool, in combination with other tools, for identifying potential prostate disease, including cancer .
New prostate cancer testing guidelines from the American Cancer Society are causing confusion, now local specialists hope to clear some of that up.
Abbott announced that it has entered into an agreement with GlaxoSmithKline to develop a molecular diagnostic test intended for use as an aid in selecting patients who may benefit from a skin cancer treatment in development by GSK.
A new study, led by researchers at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center, demonstrates that acupuncture may be an effective therapy for joint pain and stiffness in breast cancer patients who are being treated with commonly used hormonal therapies.
Sanofi-aventis announced today results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based ...